GENE ONLINE|News &
Opinion
Blog

Merck
Trials & Approvals HIV
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
Trials & Approvals Merck
Merck Presents Positive News For Keytruda Combination in NSCLC
2022-09-13
Trials & Approvals Breast Cancer
AstraZeneca and Merck’s HER2-negative Breast Cancer Treatment Wins Yet Another Approval
2022-08-25
Trials & Approvals Merck
Merck’s Anticoagulant Therapy Scores Fast Track Designation From FDA
2022-08-23
Deals Orna Therapeutics
Orna Therapeutics Secures Multi-Billion RNA Deal With Merck After $221 Million Series B
2022-08-17
Trials & Approvals Merck
FDA Finds Carcinogen In Merck’s Diabetes Drug, Allows Continued Sales To Avoid Shortage
2022-08-11
Deals Alzheimer's Disease
Merck Dangles $1.1 Billion For Cerevance To Discover New Targets For Alzheimer’s
2022-08-10
Special BIO Asia-Taiwan
BIO Asia-Taiwan 2022: The Future Of CGT In Taiwan
2022-08-08
Trials & Approvals Liver Cancer
Merck and Eisai Come Up Short in the Clinic with Liver Cancer Combination Therapy
2022-08-04
Licensing Merck
Oncology Research Collaboration between Kelun-Biotech and MSD
2022-07-27
M&A Merck
Merck Reportedly Interested in Potential $40 Billion SeaGen Buyout
2022-07-08
Trials & Approvals Pneumococcal Vaccine
FDA Blesses Merck’s Pneumococcal Vaccine for Pediatric Use
2022-06-23
Funding Protein Degraders
Proxygen Eligible For €495 Million in Molecular Glue Degrader Collaboration with Merck KGaA
2022-06-06
Trials & Approvals Merck
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
Licensing Merck
Kelun Pharmaceuticals to Receive Up To $1.4 Billion From Merck in Lowkey Deal
2022-05-19
1 2 3 4 … 7
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top